Literature DB >> 10927133

Target volumes in radiotherapy for high-grade malignant glioma of the brain.

E P Jansen1, L G Dewit, M van Herk, H Bartelink.   

Abstract

Delineation of the clinical target volume (CTV) in radiation treatment planning of high-grade glioma is a controversial issue. The use of computerized tomography (CT) and magnetic resonance imaging (MRI) has greatly improved the accuracy of tumor localization in three-dimensional planning. This review aims at critically analyzing available literature data in which tumor extent of high-grade glioma has been assessed using CT and/or MRI and relating this to postmortem observations. Attention is given to the pattern of tumor spread at initial presentation and to tumor recurrence pattern after external beam irradiation. Special emphasis is given to the site of tumor regrowth after radiation treatment in relation to the boundaries of the CTV. Guidelines for delineating CTV will be inferred from this information, taking data on radiation effects on the normal brain into account.

Entities:  

Mesh:

Year:  2000        PMID: 10927133     DOI: 10.1016/s0167-8140(00)00216-4

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  35 in total

1.  Whole-brain N-acetylaspartate spectroscopy and diffusion tensor imaging in patients with newly diagnosed gliomas: a preliminary study.

Authors:  M Inglese; S Brown; G Johnson; M Law; E Knopp; O Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

2.  Serial diffusion tensor imaging to characterize radiation-induced changes in normal-appearing white matter following radiotherapy in patients with adult low-grade gliomas.

Authors:  Mohammad Haris; Shaleen Kumar; Mani Karthick Raj; Koilpillai Joseph Maria Das; Shantanu Sapru; Sanjay Behari; Ram Kishore Singh Rathore; Ponnada A Narayana; Rakesh Kumar Gupta
Journal:  Radiat Med       Date:  2008-04

3.  What is the best way to evaluate clinical target volume for radiotherapy of brain tumors?

Authors:  Alba Fiorentino; Piernicola Pedicini; Rocchina Caivano; Vincenzo Fusco
Journal:  CNS Oncol       Date:  2013-11

4.  Corticospinal tract-sparing intensity-modulated radiotherapy treatment planning.

Authors:  Hiroshi Igaki; Akira Sakumi; Akitake Mukasa; Kuniaki Saito; Akira Kunimatsu; Yoshitaka Masutani; Shunya Hanakita; Kenji Ino; Akihiro Haga; Keiichi Nakagawa; Kuni Ohtomo
Journal:  Rep Pract Oncol Radiother       Date:  2014-07-15

5.  Radiation treatment parameters for re-irradiation of malignant glioma.

Authors:  M Niyazi; M Söhn; S B Schwarz; P Lang; C Belka; U Ganswindt
Journal:  Strahlenther Onkol       Date:  2012-02-22       Impact factor: 3.621

6.  The impact of computed tomography slice thickness on the assessment of stereotactic, 3D conformal and intensity-modulated radiotherapy of brain tumors.

Authors:  R Caivano; A Fiorentino; P Pedicini; G Califano; V Fusco
Journal:  Clin Transl Oncol       Date:  2013-09-20       Impact factor: 3.405

7.  Generating synthetic CTs from magnetic resonance images using generative adversarial networks.

Authors:  Hajar Emami; Ming Dong; Siamak P Nejad-Davarani; Carri K Glide-Hurst
Journal:  Med Phys       Date:  2018-06-14       Impact factor: 4.071

Review 8.  11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas.

Authors:  Tarun Singhal; Tanjore K Narayanan; Viney Jain; Jogeshwar Mukherjee; Joseph Mantil
Journal:  Mol Imaging Biol       Date:  2007-10-24       Impact factor: 3.488

9.  Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study.

Authors:  M Balducci; B Diletto; S Chiesa; G R D'Agostino; M A Gambacorta; M Ferro; C Colosimo; G Maira; C Anile; V Valentini
Journal:  Strahlenther Onkol       Date:  2014-01-17       Impact factor: 3.621

10.  Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison.

Authors:  Marc D Piroth; Michael Pinkawa; Richard Holy; Gabriele Stoffels; Cengiz Demirel; Charbel Attieh; Hans J Kaiser; Karl J Langen; Michael J Eble
Journal:  Radiat Oncol       Date:  2009-11-23       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.